CLOCK and glioblastoma: In previous studies, application of p38 MAPK inhibitors SB203580 or SB202190 to U20S human osteosarcoma cells, and rat C6 glioblastoma cells, led to period lengthening of clock gene rhythms, suggesting that p38 MAPK modulates the activity of core clock components [41].